Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast

G. Adjorlolo-Johnson, K. M. De Cock, E. Ekpini, K. M. Vetter, T. Sibailly, K. Brattegaard, D. Yavo, R. Doorly, J. P. Whitaker, L. Kestens and al. et
Projet RETRO-CI, Abidjan, Ivory Coast.

OBJECTIVE--To compare mother-to-child transmission of human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2, respectively) and to assess the impact of maternal HIV-1 and HIV-2 infections on child survival. DESIGN--Prospective cohort study. SETTING--Maternal and child health center in a lower socioeconomic class district of Abidjan, Ivory Coast. PARTICIPANTS--A total of 18,099 women delivering between 1990 and 1992 were tested for HIV-1 and HIV-2 antibodies. A cohort of 613 pregnant women and their infants was followed prospectively (138 women reactive to HIV-1, 132 reactive to HIV-2, 69 reactive to both viruses, and 274 HIV-seronegative). MAIN OUTCOME MEASURES--Rates of perinatal transmission for HIV-1, HIV-2, and both viruses, determined from results of serological and polymerase chain reaction tests on children; survival of infants born to HIV-1-positive, HIV-2-positive, dually reactive, and HIV-seronegative women. RESULTS--Of the 18,099 women tested, 9.4% were reactive to HIV-1 alone, 1.6% to HIV-2 alone, and 1.0% to both viruses. The rate of perinatal transmission of HIV-1 was 24.7% (95% confidence interval [CI], 15.8% to 33.7%), compared with 1.2% (95% CI, 0.0% to 3.5%) for HIV-2 (relative risk, 21.3; 95% CI, 2.9 to 154.3). Overall, 19.0% (95% CI, 9.0% to 29.0%) of infants of dually reactive women became infected; of the 11 children concerned, 10 were infected with HIV-1 and one with HIV-1 and HIV-2. Infants of HIV-seropositive mothers had a reduced survival; mortality rates were 15.1, 13.0, 6.5, and 3.4 deaths per 100 child-years, respectively, for children of HIV-1-positive, dually reactive, HIV-2-positive, and HIV-seronegative women. CONCLUSIONS--The rate of perinatal transmission of HIV-2 (1.2%) was much lower than the rate of perinatal transmission of HIV-1 (24.7%), and this was associated with more favorable survival for infants of HIV-2-infected mothers. Dually reactive women could transmit both viruses, although transmission usually involved HIV-1 only. Public health guidelines should incorporate advice that perinatal transmission of HIV-2 is rare.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mortality among HIV-1- and Human Herpesvirus Type 8-Affected Mother-Infant Pairs in Zambia
Wojcicki et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2238-2243.
ABSTRACT | FULL TEXT  

Higher Homologous and Lower Cross-Reactive Gag-Specific T-Cell Responses in Human Immunodeficiency Virus Type 2 (HIV-2) Than in HIV-1 Infection
Jennes et al.
J. Virol. 2008;82:8619-8628.
ABSTRACT | FULL TEXT  

Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial
Benn et al.
BMJ 2008;336:1416-1420.
ABSTRACT | FULL TEXT  

Effect of vitamin A supplementation with BCG vaccine at birth on vitamin A status at 6 wk and 4 mo of age
Fisker et al.
Am. J. Clin. Nutr. 2007;86:1032-1039.
ABSTRACT | FULL TEXT  

BCG vaccination scar associated with better childhood survival in Guinea-Bissau
Roth et al.
Int J Epidemiol 2005;34:540-547.
ABSTRACT | FULL TEXT  

Polymorphism and Drug-Selected Mutations in the Protease Gene of Human Immunodeficiency Virus Type 2 from Patients Living in Southern France
Colson et al.
J. Clin. Microbiol. 2004;42:570-577.
ABSTRACT | FULL TEXT  

Greater CD8+ TCR Heterogeneity and Functional Flexibility in HIV-2 Compared to HIV-1 Infection
Lopes et al.
J. Immunol. 2003;171:307-316.
ABSTRACT | FULL TEXT  

Human immunodeficiency virus type 2
Reeves and Doms
J. Gen. Virol. 2002;83:1253-1265.
FULL TEXT  

Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal
Seck et al.
Sex. Transm. Infect. 2001;77:190-193.
ABSTRACT | FULL TEXT  

Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo
Popper et al.
J. Virol. 2000;74:1554-1557.
ABSTRACT | FULL TEXT  

Natural History of Human Immunodefiency Virus Type 1 Infection in Children: A Five-Year Prospective Study in Rwanda
Spira et al.
Pediatrics 1999;104:56e-56.
ABSTRACT | FULL TEXT  

Dysregulation through the NF-kappa B Enhancer and TATA Box of the Human Immunodeficiency Virus Type 1 Subtype E Promoter
Montano et al.
J. Virol. 1998;72:8446-8452.
ABSTRACT | FULL TEXT  

Virological and Molecular Demonstration of Human Immunodeficiency Virus Type 2 Vertical Transmission
Cavaco-Silva et al.
J. Virol. 1998;72:3418-3422.
ABSTRACT | FULL TEXT  

Ethics of Placebo-Controlled Trials of Zidovudine to Prevent the Perinatal Transmission of HIV in the Third World
Merson et al.
NEJM 1998;338:836-841.
FULL TEXT